Our Managing Director Jenny Murray writes about the challenges facing the use of FBS in research and manufacturing. A former Chair of the ISIA, she discusses the issues surrounding FBS, in the past, now and in the future. Writing in an article in BioProcess International, she concludes it is the responsibility of the serum industry as a whole to address these concerns and find solutions.